Given the unusual location of MPO on immunohistochemistry (nuclear) and MPO gene expression being associated with CAD, we were also interested in investigating whether differences in MPO gene expression may have reflected different levels of differentiation of the ECFCs. The gene discussed is MPO; the disease is coronary artery disorder.